Give reason to choose generic, Sunshine Act shows problems, CSL $210m expansion, NSAIDs renal risk, and much more
Click here to download Pharmacy Daily for Thursday 9th October 2014
PARTNER SITES
Other recent headlines
-
Legal action for Montu
Friday | Apr 19 2024MONTU Group, its subsidiary Alternaleaf Pty Ltd, and their common director Christopher Strauch are facing legal action by the Therapeutic Goods Administration (TGA) in the Federal Court of Australia for alleged unlawful advertising on the effectiveness of their medicinal cannabis products.
-
Call to unblock wait times
Friday | Apr 19 2024AUSTRALIA’S public hospitals are facing their lengthiest wait times on record for planned surgeries, with emergency departments struggling under access blockages, according to the latest annual Public Hospital Report Card by the Australian Medical Association (AMA).
-
New pelvic pain study
Friday | Apr 19 2024THE University of South Australia has released a new study to help healthcare workers better support women with persistent pelvic pain, including symptoms that are suggestive of gynaecological, lower urinary tract, bowel, sexual, and pelvic floor dysfunction.
to top